Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 3/20 | 0.48 |
| ▸ | MIF | P14174 | 14/20 | 0.47 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7504576 | 0.92 | NAMPT (0.48) | RAB9AMIFHDAC6NPC1SMN1; SMN2 | |
| SCHEMBL7504359 | 0.91 | QDPR (0.46) | RAB9AMIFHDAC6NPC1SMN1; SMN2 | |
| SCHEMBL7505583 | 0.90 | RAB9A (0.45) | RAB9AMIFHDAC6NPC1SMN1; SMN2 | |
| SCHEMBL7501044 | 0.88 | RAB9A (0.43) | RAB9AMIFHDAC6NPC1SMN1; SMN2 | |
| SCHEMBL7501060 | 0.88 | RAB9A (0.43) | RAB9AMIFHDAC6NPC1SMN1; SMN2 | |
| SCHEMBL7508392 | 0.82 | RAB9A (0.43) | RAB9AMIFHDAC6NPC1SMN1; SMN2 | |
| SCHEMBL7505771 | 0.80 | MIF (0.38) | RAB9AMIFHDAC6NPC1SMN1; SMN2 | |
| SCHEMBL7502020 | 0.78 | MIF (0.39) | RAB9AMIFHDAC6NPC1SMN1; SMN2 | |
| SCHEMBL7503942 | 0.78 | MIF (0.43) | MIFHDAC6 | |
| SCHEMBL7507914 | 0.77 | RAB9A (0.46) | RAB9AMIFHDAC6NPC1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5990136-A | EFFECTIVE AGAINST GRAMPOSITIVE AEROBIC BACTERIA, E.G. MULTIPLY-RESISTANT STAPHYLOCOCCI AND STREPTOCOCCI, AS WELL AS ANAEROBIC ORGANISMS, E.G. BACTEROIDES, CLOSTRIDIA, MYCOBACTERIUM TUBERCULOSIS AND MYCOBACTERIUM AVIUM | PHARMACIA & UPJOHN COMPANY (US) | 1999-11-23 | — | — | US | claimed |
| EP-0920421-B1 | ISOXAZOLINE DERIVATIVES USEFUL AS ANTIMICROBIALS | UPJOHN CO (US) | 2002-11-06 | — | — | EP | disclosed |
| US-6093736-A | ANTIBACTERIAL AGENTS | PHARMACIA & UPJOHN COMPANY | 2000-07-25 | — | — | US | disclosed |
| US-5990136-A | EFFECTIVE AGAINST GRAMPOSITIVE AEROBIC BACTERIA, E.G. MULTIPLY-RESISTANT STAPHYLOCOCCI AND STREPTOCOCCI, AS WELL AS ANAEROBIC ORGANISMS, E.G. BACTEROIDES, CLOSTRIDIA, MYCOBACTERIUM TUBERCULOSIS AND MYCOBACTERIUM AVIUM | PHARMACIA & UPJOHN COMPANY (US) | 1999-11-23 | — | — | US | disclosed |